Kanion Pharmaceutical Brand Ranking
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Kanion Pharmaceutical

Kanion Pharmaceutical

Jiangsu Kanion Pharmaceutical Co., Ltd.
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

Jiangsu Kangyuan Pharmaceutical Co., Ltd. is a large traditional Chinese medicine enterprise integrating drug research and development, production and sales. It is a national key high-tech enterprise and a national technological innovation demonstration enterprise. It currently has more than 5,000 employees. Kangyuan Pharmaceutical has built many national scientific research platforms such as the "National Key Laboratory of New Technology of Traditional Chinese Medicine and Pharmaceutical Process". In 2018, the laboratory was rated as the "National Key Laboratory of Excellent Enterprises". Kangyuan Pharmaceutical has successively won 47 national-level new traditional Chinese medicine drugs and 331 invention patents authorized; undertaken more than 50 scientific and technological projects; won 1 second prize of national technological invention, 2 second prizes of national scientific and technological progress, and provincial and ministerial scientific and technological progress 8 first prizes (including 2 first prizes for science and technology progress in Jiangsu Province). Guizhi Fuling Jiaoxiang has completed the Phase II clinical trial of the United States and is a demonstration variety of internationalization of traditional Chinese medicine in my country.

The company adheres to the historical mission of "revitalizing Chinese medicine and serving the motherland", and has formed a cluster innovation and development with "Traditional medicine, chemical medicine, and biopharmaceuticals" as the main line, and takes the traditional Chinese medicine cultural health industry and health products as the two wings. development system. Achieve the simultaneous development of the "quality improvement" and "scale expansion" of the big health industry, and comprehensively enhance the core competitiveness of the enterprise.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号